Collegium Pharmaceutical (COLL) Net Cash Flow (2014 - 2026)

Collegium Pharmaceutical's Net Cash Flow history runs 13 years deep, the most recent figure standing at $37.4 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 82.59% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $172.5 million (up 253.21% YoY), while the FY2025 annual figure was $155.5 million, up 208.48% from the prior year.
• Net Cash Flow was $37.4 million for Q1 2026 at Collegium Pharmaceutical, down from $81.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $95.8 million in Q1 2023 to a low of -$108.9 million in Q3 2024.
• Historically, Net Cash Flow has averaged $5.9 million across 5 years, with a median of $16.0 million in 2022.
• Biggest YoY gain for Net Cash Flow was 680.51% in 2022; the steepest drop was 1019.16% in 2022.
• A 5-year view of Net Cash Flow shows it stood at $39.6 million in 2022, then slumped by 149.5% to -$19.6 million in 2023, then surged by 261.37% to $31.6 million in 2024, then soared by 156.79% to $81.2 million in 2025, then tumbled by 53.92% to $37.4 million in 2026.
• The last three Net Cash Flow figures came in at $37.4 million (Q1 2026), $81.2 million (Q4 2025), and $32.8 million (Q3 2025), per Business Quant data.